Cargando…
Does nosocomial COVID-19 result in increased 30-day mortality? A multi-centre observational study to identify risk factors for worse outcomes in patients with COVID-19
This study aimed to determine whether nosocomial coronavirus disease 2019 (COVID-19) has a worse outcome compared with community-acquired COVID-19. This was a prospective cohort study of all hospitalized patients with confirmed COVID-19 in three acute hospitals on 9(th) April 2020. Patients were fol...
Autores principales: | Khan, K.S., Reed-Embleton, H., Lewis, J., Saldanha, J., Mahmud, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd on behalf of The Healthcare Infection Society.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495174/ https://www.ncbi.nlm.nih.gov/pubmed/32950587 http://dx.doi.org/10.1016/j.jhin.2020.09.017 |
Ejemplares similares
-
Angiotensin converting enzyme inhibitors do not increase the risk of poor outcomes in COVID-19 disease. A multi-centre observational study
por: Khan, Khurram Shahzad, et al.
Publicado: (2020) -
Does asthma make COVID-19 worse?
por: Hegde, Samarth
Publicado: (2020) -
Vitamin D deficiency predicts 30-day hospital mortality of adults with COVID-19
por: Neves, Fabio Fernandes, et al.
Publicado: (2022) -
Does hereditary angioedema make COVID-19 worse?
por: Xu, Yingyang, et al.
Publicado: (2020) -
Does Copper Prevent Nosocomial Transmission of COVID-19?
por: Coutureau, Claire, et al.
Publicado: (2021)